Comparator: placebo to pioglitazone

DRUG2 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Type 2 Diabetes MellitusType 2 Diabetes Mellitus (T2DM)

Phase 1

Sitagliptin and Pioglitazone Mechanism of Action Study in Type 2 Diabetes Mellitus (0431-061)

CompletedNCT00511108

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus (T2DM)

Start: 2007-07-11End: 2009-02-24Updated: 2017-05-12

Phase 3

A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

CompletedNCT01076075

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2010-06-03End: 2012-01-19Updated: 2017-06-05